雌激素受体低阳性 (ER低) 乳腺癌:一个独特的临床和病理实体
Gavino Faa1,2, Eleonora Lai3, Pina Ziranu3
1Department of Medical Sciences and Public Health, University of Cagliari, AOU Cagliari, 09124 Cagliari, Italy.
Current oncology (Toronto, Ont.)
|February 26, 2026
概括
低ER乳腺癌,定义为1-9%的ER表达,与三阴性乳腺癌具有共同的特征. 人工智能工具对准确的评估和个性化的治疗策略有前途.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
- 生物医学工程 生物医学工程
背景情况:
- 低ER的乳腺癌 (1-9%的ER表达) 是一个独特的亚型.
- 它与三阴性乳腺癌具有分子和临床相似之处.
- 由于方法的变化,准确的ER评估具有挑战性.
研究的目的:
- 审查当前对低ER乳腺癌的见解.
- 讨论不断发展的治疗策略.
- 探索人工智能在管理这种亚型中的作用.
主要方法:
- 对病理和临床数据的文献综述.
- 对治疗反应的分析,包括化疗和化疗免疫疗法.
- 对ER量化新兴人工智能工具的评估.
主要成果:
- 低ER瘤对化疗和化疗免疫疗法表现出敏感性.
- 这些瘤与三阴性乳腺癌具有相同的侵略性行为和分子特征.
- 人工智能工具,包括数字病理学和深度学习,显示出改善ER评估和患者分层的潜力.
结论:
- 低ER乳腺癌需要量身定制的治疗策略.
- 化疗和化疗免疫疗法是有前途的治疗选择.
- 人工智能驱动的方法为个性化治疗优化提供了未来的潜力.
相关概念视频
01:31Transducer Mechanism: Nuclear Receptors
3.6K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
3.6K
02:39lncRNA - Long Non-coding RNAs
10.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K